GCL
TERN

Glazer Capital LLC’s Terns Pharmaceuticals TERN Stock Holding History

Glazer Capital LLC’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,295,498
Closed -$121M – 594
2026
Q1 		$121M Buy
+2,295,498
New +$94.3M 2.57% 10

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glazer Capital LLC's TERN Position: Q2 2026 in Review

Glazer Capital LLC sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,295,498 shares — an estimated $121M sold.

Glazer Capital LLC first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $121M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Glazer Capital LLC reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Glazer Capital LLC sold 2,295,498 Terns Pharmaceuticals shares in Q2 2026, an estimated $121M.
  • Glazer Capital LLC first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Glazer Capital LLC's Terns Pharmaceuticals position peaked at $121M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.